Rituxan (rituximab) - Roche
mycophenolate mofetil - Generic mfg.
A Rare Case of Antitubular Basement Membrane Disease (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0455; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "He received high-dose corticosteroids and mycophenolate mofetil...He was treated with plasmapheresis and rituximab but progressed to end-stage kidney disease (ESKD)...Due to lack of an available clinical assay, anti-TBM antibody titers were not sent. This case highlights a rare disease with poor prognosis for which additional research and diagnostic testing is needed." 
Clinical • Genito-urinary Cancer • Immunology • Infectious Disease • Myositis • Nephrology • Prostate Cancer • Rare Diseases • Renal Disease • Solid Tumor • MB
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4554088
 
Hannah Angle; Vimal K. Derebail; Vanessa Moreno; Sam Albadri; Koyal Jain
 
Oct 2, 2026
 
Prev Next